These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3884257)
1. In vivo administration of interleukin-2. Cheever MA; Greenberg PD Contemp Top Mol Immunol; 1985; 10():263-82. PubMed ID: 3884257 [No Abstract] [Full Text] [Related]
2. Replicative senescence of interleukin-2-dependent human T lymphocytes. Flow cytometric characteristics of phenotype changes. Jaruga E; Skierski J; Radzieszewska E; Sikora E Ann N Y Acad Sci; 2000 Jun; 908():310-4. PubMed ID: 10911973 [No Abstract] [Full Text] [Related]
4. Herpes simplex virus replication in interleukin-2-stimulated human T cells. Hammer SM; Gillis JM J Infect Dis; 1985 Mar; 151(3):544-8. PubMed ID: 2982967 [No Abstract] [Full Text] [Related]
5. [Stimulation of phosphoinositide turnover is an important but not a sole condition for activation of human T-lymphocyte proliferation by phytohemagglutinin and interleukin 2]. Korichneva IL; Rudchenko SA; Krasnikova TL; Grigorian GIu; Smirnov VN Dokl Akad Nauk SSSR; 1989; 304(1):221-4. PubMed ID: 2544387 [No Abstract] [Full Text] [Related]
6. Interleukin-2- and phytohemagglutinin-activated proliferation of human T-lymphocytes is accompanied by stimulation of phosphoinositide turnover. Korichneva IL; Grigorian GYu ; Krasnikova TL; Rudchenko SA; Tkachuk VA Biochim Biophys Acta; 1989 Nov; 1014(2):173-7. PubMed ID: 2554974 [TBL] [Abstract][Full Text] [Related]
7. [Synergism of effect between phytohemagglutinin, interleukin 2 and methotrexate on the protidosynthetic activity of human lymphocytes]. Ciaiolo C Minerva Med; 1987 Jul; 78(13):941-2. PubMed ID: 3496561 [No Abstract] [Full Text] [Related]
8. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium. Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190 [No Abstract] [Full Text] [Related]
9. Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis. Menéndez JL; Girón JA; Manzano L; Garrido A; Abreu L; Albillos A; Durántez A; Alvarez-Mon M Hepatology; 1992 Oct; 16(4):931-6. PubMed ID: 1398499 [TBL] [Abstract][Full Text] [Related]
10. [Reason for the damping effect of tumor cells on human T-lymphocytes]. Strelkov LA; Mikhaĭlova AA; Sapozhnikov AM; Petrov RV Dokl Akad Nauk; 1996 Mar; 347(2):278-80. PubMed ID: 8768094 [No Abstract] [Full Text] [Related]
11. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. Lotz M; Jirik F; Kabouridis P; Tsoukas C; Hirano T; Kishimoto T; Carson DA J Exp Med; 1988 Mar; 167(3):1253-8. PubMed ID: 3127525 [TBL] [Abstract][Full Text] [Related]
12. Dipyridamol inhibits activation of human T lymphocytes in vitro. Bruserud O Clin Immunol Immunopathol; 1987 Jan; 42(1):102-9. PubMed ID: 3098479 [TBL] [Abstract][Full Text] [Related]
13. Early supernatants of mitogen-stimulated mononuclear cells promote long-term IL-2-dependent growth of human T lymphocytes. Siwicki JK; Steffen JA Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):109-17. PubMed ID: 8915514 [TBL] [Abstract][Full Text] [Related]
14. Phytohemagglutinin-induced human T-lymphocyte colonies: cellular and T-cell growth factor requirements are the same as for suspension culture growth. Ruscetti FW Nat Immun Cell Growth Regul; 1983-1984; 3(2):102-12. PubMed ID: 6333587 [TBL] [Abstract][Full Text] [Related]
15. Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2. Hank JA; Sosman JA; Kohler PC; Bechhofer R; Storer B; Sondel PM J Biol Response Mod; 1990 Feb; 9(1):5-14. PubMed ID: 2181071 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 induced changes in mononuclear cell surface charge. Jenkins R; Williams AC; Limb GA; Brown KA; Dumonde DC Adv Exp Med Biol; 1988; 237():433-8. PubMed ID: 3267058 [No Abstract] [Full Text] [Related]
17. Interleukin 4 drives phytohemagglutinin-activated T cells through several cell cycles: no synergism between interleukin 2 and interleukin 4. Lehrnbecher T; Merz H; Sebald W; Poot M Cytokine; 1991 Nov; 3(6):593-7. PubMed ID: 1724186 [TBL] [Abstract][Full Text] [Related]
19. One third of murine splenic T cells are cytotoxic precursors induced to grow by leucoagglutinin and TCGF. Larsson EL Scand J Immunol; 1981 May; 15(5):515-9. PubMed ID: 6980449 [No Abstract] [Full Text] [Related]
20. Alterations in beta-adrenoceptor density on T-lymphocytes upon activation with interleukin-2 and phytohaemagglutinin. Korichneva IL; Tkachuk VA Biomed Sci; 1990 Jan; 1(1):84-8. PubMed ID: 1966667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]